Quantcast

Ventricular Arrhythmia Global Clinical Trials Review, H2, 2013

April 7, 2014

LONDON, April 7, 2014 /PRNewswire/ — Reportbuyer.com has added a new market research report:

Ventricular Arrhythmia Global Clinical Trials Review, H2, 2013

Ventricular Arrhythmia Global Clinical Trials Review, H2, 2013

Summary

GlobalData’s clinical trial report, “Ventricular Arrhythmia Global Clinical Trials Review, H2, 2013″ provides data on the Ventricular Arrhythmia clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Ventricular Arrhythmia. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Ventricular Arrhythmia. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Ventricular Arrhythmia 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials by Country 8
Top Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by BRIC Nations 15
Clinical Trials by G7 Nations 16
Clinical Trials in G7 Nations by Trial Status 17
Clinical Trials by E7 Nations 18
Clinical Trials in E7 Nations by Trial Status 19
Clinical Trials by Phase 20
In Progress Trials by Phase 21
Clinical Trials by Trial Status 22
Unaccomplished Trials of Ventricular Arrhythmia 23
Subjects Recruited Over a Period of Time 25
Prominent Sponsors 26
Top Companies Participating in Ventricular Arrhythmia Therapeutics Clinical Trials 28
Prominent Drug Comparison 30
Clinical Trial Profiles 31
Clinical Trial Overview of Top Companies 31
St. Jude Medical, Inc. 31
Clinical Trial Overview of St. Jude Medical, Inc. 31
Sanofi 32
Clinical Trial Overview of Sanofi 32
Trillium Health Care Products Inc. 33
Clinical Trial Overview of Trillium Health Care Products Inc. 33
Pfizer Inc. 34
Clinical Trial Overview of Pfizer Inc. 34
Johnson & Johnson 35
Clinical Trial Overview of Johnson & Johnson 35
Hospira, Inc. 36
Clinical Trial Overview of Hospira, Inc. 36
Forest Laboratories, Inc. 37
Clinical Trial Overview of Forest Laboratories, Inc. 37
Biotronik SE & Co. KG 38
Clinical Trial Overview of Biotronik SE & Co. KG 38
Clinical Trial Overview of Top Institutes / Government 39
National Heart, Lung, and Blood Institute 39
Clinical Trial Overview of National Heart, Lung, and Blood Institute 39
Nanjing Medical University 40
Clinical Trial Overview of Nanjing Medical University 40
University of Schleswig-Holstein 41
Clinical Trial Overview of University of Schleswig-Holstein 41
Medizinische Hochschule Hannover 42
Clinical Trial Overview of Medizinische Hochschule Hannover 42
Tel-Aviv Sourasky Medical Center 43
Clinical Trial Overview of Tel-Aviv Sourasky Medical Center 43
Leiden University Medical Center 44
Clinical Trial Overview of Leiden University Medical Center 44
Emory University 45
Clinical Trial Overview of Emory University 45
University of Pennsylvania 46
Clinical Trial Overview of University of Pennsylvania 46
Lawson Health Research Institute 47
Clinical Trial Overview of Lawson Health Research Institute 47
University of Rochester 48
Clinical Trial Overview of University of Rochester 48
Five Key Clinical Profiles 49
Abbreviations 65
Definitions 65
Research Methodology 66
Secondary Research 66
About GlobalData 67
Contact Us 67
Disclaimer 67
Source 68

List of Tables

Ventricular Arrhythmia Therapeutics Market, Global, Clinical Trials by Zone, 2013* 7
Ventricular Arrhythmia Therapeutics Market, Global, Clinical Trials by Top Countries, 2013* 8
Ventricular Arrhythmia Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2013* 9
Ventricular Arrhythmia Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2013* 10
Ventricular Arrhythmia Therapeutics Clinical Trials, Europe, Top Five Countries, 2013* 11
Ventricular Arrhythmia Therapeutics Clinical Trials, North America, Top Countries, 2013* 12
Ventricular Arrhythmia Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2013* 13
Ventricular Arrhythmia Therapeutics Clinical Trials, Central and South America, Top Countries, 2013* 14
Ventricular Arrhythmia Therapeutics Clinical Trials, BRIC Countries, 2013* 15
Ventricular Arrhythmia Therapeutics Clinical Trials, G7 Countries, 2013* 16
Ventricular Arrhythmia Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2013* 17
Ventricular Arrhythmia Therapeutics Clinical Trials, E7 Countries, 2013* 18
Ventricular Arrhythmia Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2013* 19
Ventricular Arrhythmia Therapeutics Market, Global, Clinical Trials by Phase, 2013* 20
Ventricular Arrhythmia Therapeutics Market, Global, Clinical Trials In Progress by Phase 2013* 21
Ventricular Arrhythmia Therapeutics Market, Global, Clinical Trials by Trial Status, 2013* 22
Ventricular Arrhythmia Therapeutics Market, Global, Withdrawn Clinical Trials, 2013* 23
Ventricular Arrhythmia Therapeutics Market, Global, Terminated Clinical Trials, 2013* 24
Ventricular Arrhythmia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2007-2012 25
Ventricular Arrhythmia Therapeutics Clinical Trials, Global, Key Sponsors, 2013* 27
Ventricular Arrhythmia Therapeutics Clinical Trials, Global, Top Companies by Phase, 2013* 29
Ventricular Arrhythmia Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2013* 30
Ventricular Arrhythmia Therapeutics Clinical Trials Market, Global, Clinical Trials by St. Jude Medical, Inc., 2013* 31
Ventricular Arrhythmia Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi, 2013* 32
Ventricular Arrhythmia Therapeutics Clinical Trials Market, Global, Clinical Trials by Trillium Health Care Products Inc., 2013* 33
Ventricular Arrhythmia Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2013* 34
Ventricular Arrhythmia Therapeutics Clinical Trials Market, Global, Clinical Trials by Johnson & Johnson, 2013* 35
Ventricular Arrhythmia Therapeutics Clinical Trials Market, Global, Clinical Trials by Hospira, Inc., 2013* 36
Ventricular Arrhythmia Therapeutics Clinical Trials Market, Global, Clinical Trials by Forest Laboratories, Inc., 2013* 37
Ventricular Arrhythmia Therapeutics Clinical Trials Market, Global, Clinical Trials by Biotronik SE & Co. KG, 2013* 38
Ventricular Arrhythmia Therapeutics Clinical Trials Market, Global, Clinical Trials by National Heart, Lung, and Blood Institute, 2013* 39
Ventricular Arrhythmia Therapeutics Clinical Trials Market, Global, Clinical Trials by Nanjing Medical University, 2013* 40
Ventricular Arrhythmia Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Schleswig-Holstein, 2013* 41
Ventricular Arrhythmia Therapeutics Clinical Trials Market, Global, Clinical Trials by Medizinische Hochschule Hannover, 2013* 42
Ventricular Arrhythmia Therapeutics Clinical Trials Market, Global, Clinical Trials by Tel-Aviv Sourasky Medical Center, 2013* 43
Ventricular Arrhythmia Therapeutics Clinical Trials Market, Global, Clinical Trials by Leiden University Medical Center, 2013* 44
Ventricular Arrhythmia Therapeutics Clinical Trials Market, Global, Clinical Trials by Emory University, 2013* 45
Ventricular Arrhythmia Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Pennsylvania, 2013* 46
Ventricular Arrhythmia Therapeutics Clinical Trials Market, Global, Clinical Trials by Lawson Health Research Institute, 2013* 47
Ventricular Arrhythmia Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Rochester, 2013* 48

List of Figures

Ventricular Arrhythmia Therapeutics Market, Global, Clinical Trials by Zone (%), 2013* 7
Ventricular Arrhythmia Therapeutics Market, Global, Clinical Trials by Top Countries, 2013* 8
Ventricular Arrhythmia Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2013* 9
Ventricular Arrhythmia Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2013* 10
Ventricular Arrhythmia Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2013* 11
Ventricular Arrhythmia Therapeutics Clinical Trials, North America, Top Countries (%), 2013* 12
Ventricular Arrhythmia Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2013* 13
Ventricular Arrhythmia Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2013* 14
Ventricular Arrhythmia Therapeutics Clinical Trials, BRIC Countries (%), 2013* 15
Ventricular Arrhythmia Therapeutics Clinical Trials, G7 Countries (%), 2013* 16
Ventricular Arrhythmia Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2013* 17
Ventricular Arrhythmia Therapeutics Clinical Trials, E7 Countries (%), 2013* 18
Ventricular Arrhythmia Therapeutics Market, Global, Clinical Trials by Phase (%), 2013* 20
Ventricular Arrhythmia Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2013* 21
Ventricular Arrhythmia Therapeutics Market, Global, Clinical Trials by Trial Status, 2013* 22
Ventricular Arrhythmia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2007-2012 25
Ventricular Arrhythmia Therapeutics Clinical Trials, Global, Key Sponsors, 2013* 26
Ventricular Arrhythmia Therapeutics Clinical Trials, Global, Top Companies by Phase, 2013* 28
Ventricular Arrhythmia Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2013* 30
GlobalData Methodology 66

Read the full report:
Ventricular Arrhythmia Global Clinical Trials Review, H2, 2013
http://www.reportbuyer.com/pharma_healthcare/research_rd/clinical_trials/ventricular_arrhythmia_global_clinical_trials_review.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_Discovery_and_Development

For more information:
Sarah Smith
Research Advisor at Reportbuyer.com
Email: query@reportbuyer.com
Tel: +44 208 816 85 48
Website: www.reportbuyer.com

SOURCE ReportBuyer


Source: PR Newswire



comments powered by Disqus